Instem and AstraZeneca Presenting at the British Society of Toxicological Pathology Annual Meeting
Instem and AstraZeneca to present “Cardiovascular Drug Toxicities Associated With Pharmacological Activity; Data Harmonization Makes The 'Known' Visible”
CONSHOHOCKEN, PA – November 11, 2013 - -Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that Dr. Jane Reed, Director of Safety Intelligence at Instem, will be co-presenting a poster at the British Society of Toxicological Pathology (BSTP) 28th Annual Scientific Meeting in Cheshire, UK.
The poster presentation, “Cardiovascular Drug Toxicities Associated With Pharmacological Activity; Data Harmonization Makes The “Known” Visible” has been developed in conjunction with AstraZeneca scientists from Sweden and the UK. The poster will discuss how data from Instem’s Safety Intelligence Program™ (SIP) has been combined with target profiles of drugs to identify associations between pharmacological activities and cardiac events.
The 28th Annual BSTP meeting is being held jointly with the Safety Pharmacology Society (SPS) and is sponsored by the Health and Environmental Sciences Institute (HESI). The theme of the meeting is “Integrated Cardiovascular Safety Risk Assessment for New Candidate Drugs from Functional and Pathological Data” The meeting is being held at AstraZeneca’s Alderley Park site, Cheshire, UK on November 14th & 15th.
The poster will be on display in the BSTP Exhibit Hall throughout the meeting. Instem will also be exhibiting at booth # 4, where delegates will have the opportunity to participate in a free SIP taster session. Delegates are invited to submit their cardiovascular safety question and Instem will provide a free output of the SIP ToxPath Knowledgebase to provide them with an answer.
At the BSTP booth, Instem will also be showcasing their market-leading Provantis® Pathology solution for the collection, processing and reporting of data for gross and histopathology.
The BSTP is a non-profit organization that seeks to advance pathology for the public benefit in all its aspects pertaining to the effects of extraneous substances and environmental agents to which man or other species are exposed through design or adventitiously. Additionally it seeks to foster training and advance education in toxicological pathology by providing continuing professional development seminars and educational training modules.
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600